Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

EDAP TMS SA

FOCL · Nasdaq · CIK 0001041934 · Healthcare · Medical Distribution

INSIDER SIGNAL

68.1 / 100

4 buyers · 4 purchase transaction lines · $408.5K gross purchase

WHY THIS SIGNAL?

Buyer breadthStrong
Purchase sizeModerate
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+28.0 / 35
Purchase size+13.7 / 25
Role+13.0 / 20
Recency+3.4 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Annen StevenSVP, Marketing & Product Mgmt.
○●
Shah SanketGen Counsel & Corp Secretary
○●
Rhodes RyanChief Executive Officer
○●
Mobeck Kenneth S.Chief Financial Officer
○●
LEVINE JOSHUADirector
●●
Horn David R.Director
●
● Purchase▼ Sale○ Other

Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS8
PURCHASE CONCENTRATION40%Largest buyer: WILLSEY LANCE · $237.5K
CLUSTER BUYING · 15D8 insidersPeak activity: 2026-08-14–2026-08-14

Roles in the peak window: Chief Executive Officer, Chief Financial Officer, Director, General Counsel & Corp Sec, SVP, Marketing & Product Mgmt.. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

68.1 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 68.5
  2. 68.4
  3. 68.3
  4. 68.2
  5. 68.1

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

9Purchases
0Sales
4Other Form 4 lines
13SEC filings · 365 days
BUYING9 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER4 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+0.7%
3M
-22.8%
6M
+27.0%
12M
+89.6%

Volatility & liquidity

Volatility
78.0%
Beta
—
Avg daily value
USD 486,918

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
-41.5%
ROE
-150.7%
Industry
Medical Distribution

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
259,343
Previous report
245,665
Avg daily volume
89,225
Days to cover
2.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-14WILLSEY LANCEPurchase (P)Common Stock50,000USD 4.75USD 237,500SEC filing ↗
2026-08-14Shah SanketPurchase (P)Common Stock5,000USD 4.75USD 23,750SEC filing ↗
2026-08-14Schulz FranPurchase (P)Common Stock10,000USD 4.75USD 47,500SEC filing ↗
2026-08-14Rhodes RyanPurchase (P)Common Stock21,000USD 4.75USD 99,750SEC filing ↗
2026-08-14Mobeck Kenneth S.Purchase (P)Common Stock5,000USD 4.75USD 23,750SEC filing ↗
2026-08-14LEVINE JOSHUAPurchase (P)Common Stock10,000USD 4.75USD 47,500SEC filing ↗
2026-08-14Horn David R.Purchase (P)Common Stock10,000USD 4.75USD 47,500SEC filing ↗
2026-08-14Annen StevenPurchase (P)Common Stock5,000USD 4.75USD 23,750SEC filing ↗
2026-05-11LEVINE JOSHUAPurchase (P)Common Stock10,000USD 4.22USD 42,200SEC filing ↗

Form 4 evidence

13 transaction lines in the latest 365-day window; 13 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-14WILLSEY LANCEPurchase (P)Common Stock50,000USD 4.75USD 237,500SEC filing ↗
2026-08-14Shah SanketPurchase (P)Common Stock5,000USD 4.75USD 23,750SEC filing ↗
2026-08-14Schulz FranPurchase (P)Common Stock10,000USD 4.75USD 47,500SEC filing ↗
Show recent Form 4 evidence (13 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-14WILLSEY LANCEPurchase (P)Common Stock50,000USD 4.75USD 237,500SEC filing ↗
2026-08-14Shah SanketPurchase (P)Common Stock5,000USD 4.75USD 23,750SEC filing ↗
2026-08-14Schulz FranPurchase (P)Common Stock10,000USD 4.75USD 47,500SEC filing ↗
2026-08-14Rhodes RyanPurchase (P)Common Stock21,000USD 4.75USD 99,750SEC filing ↗
2026-08-14Mobeck Kenneth S.Purchase (P)Common Stock5,000USD 4.75USD 23,750SEC filing ↗
2026-08-14LEVINE JOSHUAPurchase (P)Common Stock10,000USD 4.75USD 47,500SEC filing ↗
2026-08-14Horn David R.Purchase (P)Common Stock10,000USD 4.75USD 47,500SEC filing ↗
2026-08-14Annen StevenPurchase (P)Common Stock5,000USD 4.75USD 23,750SEC filing ↗
2026-05-12Shah SanketAward / grant (A)Common Stock67,500USD 0.00USD 0SEC filing ↗
2026-05-12Rhodes RyanAward / grant (A)Common Stock304,500USD 0.00USD 0SEC filing ↗
2026-05-12Mobeck Kenneth S.Award / grant (A)Common Stock120,000USD 0.00USD 0SEC filing ↗
2026-05-12Annen StevenAward / grant (A)Common Stock90,000USD 0.00USD 0SEC filing ↗
2026-05-11LEVINE JOSHUAPurchase (P)Common Stock10,000USD 4.22USD 42,200SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerFOCL
CIK0001041934
SectorHealthcare
IndustryMedical Distribution Yahoo Finance
SEC SIC3845 Electromedical & Electrotherapeutic Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history13 transaction lines from 2026-05-11 to 2026-08-14
9 P purchase lines · 0 S sale lines · 4 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.